INVESTOR RELATIONS

News

Date Title and Summary Additional Formats
Toggle Summary NantKwest to Participate at Upcoming Investment Conferences
NantKwest to Participate at Upcoming Investment Conferences CULVER CITY, CALIFORNIA-(BUSINESS WIRE), November 12, 2018 NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be participating at a number of investment
View HTML
Toggle Summary NantKwest to Participate at World Immunotherapy Congress
CULVER CITY, CA – March 1, 2019 - NantKwest (Nasdaq:NK), a member of the NantWorks ecosystem of companies,  a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be making two presentations at the World Immunotherapy Congress in San Diego on
View HTML
Toggle Summary NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Jun. 3, 2019-- NantKwest ( Nasdaq:NK ), a leading clinical-stage, natural killer cell based therapeutics company, today announced that Dr. Patrick Soon-Shiong and Company management will be participating in the Jefferies 2019 Annual Healthcare Conference being
View HTML
Toggle Summary NantKwest to Present at 2017 Bank of America Merrill Lynch Healthcare Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--May 15, 2017-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that members of the company's management team will be presenting at the 2017 Bank of America Healthcare Conference on Thursday, May
View HTML
Toggle Summary NantKwest to Present at 2018 Cantor Global Healthcare Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Oct. 2, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at the upcoming Cantor Global Healthcare Conference on Tuesday, October 2 nd in New York City
View HTML
Toggle Summary NantKwest to Present at Jefferies 2018 Global Healthcare Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Jun. 5, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that Dr. Patrick Soon-Shiong , Chairman & CEO of NantKwest , will be presenting and conducting one-on-one meetings at the upcoming
View HTML
Toggle Summary NantKwest to Present at the 37th Annual Canaccord Genuity Growth Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Aug. 7, 2017-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting at the 37 th Annual Canaccord Genuity Growth Conference taking place August 9-10, 2017 in
View HTML
Toggle Summary NantKwest to Present at the Jefferies Healthcare Conference on June 7, 2017
CULVER CITY, Calif. --(BUSINESS WIRE)--Jun. 2, 2017-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at the Jefferies 2017 Global Healthcare Conference on Wednesday, June 7 th , in New York City at
View HTML
Toggle Summary NantKwest to Present at the Piper Jaffray 28th Annual Health Care Conference
CULVER CITY, Calif. --(BUSINESS WIRE)--Nov. 28, 2016-- NantKwest Inc. (Nasdaq:NK) today announced that Company management will present at the Piper Jaffray 28 th Annual Health Care Conference in New York, NY at 4:00 pm Eastern Time (ET) on Tuesday, November 29, 2016 .
View HTML
Toggle Summary NantKwest to Present at Upcoming Investment and Healthcare Conferences
CULVER CITY, Calif. --(BUSINESS WIRE)--Mar. 13, 2018-- NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell-based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare conferences in the
View HTML